149 related articles for article (PubMed ID: 6457019)
21. Clinical experience with nitroimidazoles as radiosensitizers.
Dische S; Saunders MI; Anderson P; Stratford MR; Minchinton A
Int J Radiat Oncol Biol Phys; 1982; 8(3-4):335-8. PubMed ID: 7107350
[No Abstract] [Full Text] [Related]
22. Sensitizers and protectors in clinical oncology.
Phillips TL
Semin Oncol; 1981 Mar; 8(1):65-82. PubMed ID: 6264627
[No Abstract] [Full Text] [Related]
23. Pharmacokinetics and subcellular localization of radiosensitizers.
Stratford MR
BJR Suppl; 1992; 24():100-4. PubMed ID: 1290683
[No Abstract] [Full Text] [Related]
24. Increased enhancement of tumour response to X-rays and high-LET neon ions by desmethylmisonidazole relative to misonidazole.
Tenforde TS; Curtis SB; Parr SS; Afzal SM; Howard J; Lyman JT
Int J Radiat Biol Relat Stud Phys Chem Med; 1982 Jun; 41(6):677-84. PubMed ID: 6981621
[No Abstract] [Full Text] [Related]
25. Nitroheterocyclic compounds as radiation sensitizers and bioreductive drugs.
Adams GE; Stratford IJ; Bremner JC; Edwards HS; Fielden EM
Radiother Oncol; 1991; 20 Suppl 1():85-91. PubMed ID: 2020774
[No Abstract] [Full Text] [Related]
26. A randomized study of misonidazole and radiotherapy for grade 3 and 4 cerebral astrocytoma.
Bleehen NM; Wiltshire CR; Plowman PN; Watson JV; Gleave JR; Holmes AE; Lewin WS; Treip CS; Hawkins TD
Br J Cancer; 1981 Apr; 43(4):436-42. PubMed ID: 7016157
[TBL] [Abstract][Full Text] [Related]
27. Hypoxia-mediated nitro-heterocyclic drugs in the radio- and chemotherapy of cancer. An overview.
Adams GE; Stratford IJ
Biochem Pharmacol; 1986 Jan; 35(1):71-6. PubMed ID: 2934067
[No Abstract] [Full Text] [Related]
28. [Radiosensitizer: hypoxic cell radiosensitizer].
Mori T
Gan To Kagaku Ryoho; 1989 Apr; 16(4 Pt 2-2):1399-404. PubMed ID: 2525001
[TBL] [Abstract][Full Text] [Related]
29. Addition of 2-nitroimidazole radiosensitizers to cis-diamminedichloroplatinum(II) with radiation and with or without hyperthermia in the murine FSaIIC fibrosarcoma.
Herman TS; Teicher BA; Holden SA; Pfeffer MR; Jones SM
Cancer Res; 1990 May; 50(9):2734-40. PubMed ID: 2139359
[TBL] [Abstract][Full Text] [Related]
30. SR-2508: a 2-nitroimidazole amide which should be superior to misonidazole as a radiosensitizer for clinical use.
Brown JM; Yu NY; Brown DM; Lee WW
Int J Radiat Oncol Biol Phys; 1981 Jun; 7(6):695-703. PubMed ID: 6457018
[No Abstract] [Full Text] [Related]
31. Effect of acidic pH on radiosensitization of FSaIIC cells in vitro by misonidazole, etanidazole, or cis-diamminedichloroplatinum (II).
Herman TS; Teicher BA; Pfeffer MR; Khandekar V; Chapnick RM; Kalick GS; Rabow A
Radiat Res; 1990 Oct; 124(1):28-33. PubMed ID: 2146699
[TBL] [Abstract][Full Text] [Related]
32. Evaluation of nitroimidazole hypoxic cell radiosensitizers in a human tumor cell line high in intracellular glutathione.
DeGraff WG; Russo A; Gamson J; Mitchell JB
Int J Radiat Oncol Biol Phys; 1989 Apr; 16(4):1021-4. PubMed ID: 2522917
[TBL] [Abstract][Full Text] [Related]
33. A comparative investigation of nimorazole and misonidazole as hypoxic radiosensitizers in a C3H mammary carcinoma in vivo.
Overgaard J; Overgaard M; Nielsen OS; Pedersen AK; Timothy AR
Br J Cancer; 1982 Dec; 46(6):904-11. PubMed ID: 7150484
[TBL] [Abstract][Full Text] [Related]
34. Depletion of glutathione in vivo as a method of improving the therapeutic ratio of misonidazole and SR 2508.
Yu NY; Brown JM
Int J Radiat Oncol Biol Phys; 1984 Aug; 10(8):1265-9. PubMed ID: 6236185
[TBL] [Abstract][Full Text] [Related]
35. Hypoxic cell sensitizers and heavy charged particle beams may play complementary roles in killing hypoxic tumor cells.
Curtis SB; Tenforde TS; Afzal SM
Int J Radiat Oncol Biol Phys; 1984 Aug; 10(8):1203-5. PubMed ID: 6432747
[TBL] [Abstract][Full Text] [Related]
36. [Radiosensitizing effect of the nitroimidazole derivatives RK28 and DNIE on murine tumors].
Tanaka M; Fukuda H; Nakajima T; Sugimoto K; Onoyama Y; Hori H; Inayama S
Nihon Igaku Hoshasen Gakkai Zasshi; 1988 Oct; 48(10):1249-60. PubMed ID: 3222139
[No Abstract] [Full Text] [Related]
37. The current status of drug development of hypoxic cell radiosensitizers and their potential role in gynecologic oncology.
Coleman CN; Ballon SC; Howes AE; Martinez A; Halsey J; Hirst VK
Gynecol Oncol; 1984 May; 18(1):18-27. PubMed ID: 6201419
[TBL] [Abstract][Full Text] [Related]
38. The effect of hypoxic radiosensitizer after mild hyperthermia in C3H mammary carcinoma.
Ohizumi Y; Murayama C; Maezawa H; Mori T
Tokai J Exp Clin Med; 1984 Oct; 9(4):331-7. PubMed ID: 6537042
[TBL] [Abstract][Full Text] [Related]
39. Misonidazole in the clinic at Mount Vernon.
Dische S
Cancer Clin Trials; 1980; 3(2):175-8. PubMed ID: 7000388
[TBL] [Abstract][Full Text] [Related]
40. Dose-response relationships for human tumors: implications for clinical trials of dose modifying agents.
Williams MV; Denekamp J; Fowler JF
Int J Radiat Oncol Biol Phys; 1984 Sep; 10(9):1703-7. PubMed ID: 6237084
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]